stoxline Quote Chart Rank Option Currency Glossary
  
GRAIL, Inc. (GRAL)
100.4  -3.28 (-3.16%)    02-11 16:00
Open: 103.74
High: 104.115
Volume: 467,885
  
Pre. Close: 103.68
Low: 98.045
Market Cap: 3,914(M)
Technical analysis
2026-02-11 4:41:15 PM
Short term     
Mid term     
Targets 6-month :  127.27 1-year :  138.8
Resists First :  108.96 Second :  118.83
Pivot price 102.84
Supports First :  93 Second :  77.37
MAs MA(5) :  99.72 MA(20) :  102.19
MA(100) :  87.67 MA(250) :  56.86
MACD MACD :  0.7 Signal :  1.3
%K %D K(14,3) :  32 D(3) :  28
RSI RSI(14): 50.1
52-week High :  118.83 Low :  20.44
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ GRAL ] has closed above bottom band by 37.9%. Bollinger Bands are 21.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 104.17 - 104.71 104.71 - 105.11
Low: 96.93 - 97.46 97.46 - 97.88
Close: 99.54 - 100.45 100.45 - 101.15
Company Description

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

Headline News

Tue, 10 Feb 2026
GRAIL Inc (GRAL) Shares Up 5.15% on Feb 10 - GuruFocus

Sun, 08 Feb 2026
GRAIL submits FDA PMA for Galleri multi-cancer early detection test - MSN

Sun, 08 Feb 2026
Moloney Securities Asset Management LLC Has $959,000 Stock Holdings in GRAIL, Inc. $GRAL - MarketBeat

Sun, 08 Feb 2026
GRAIL, Inc. $GRAL Shares Purchased by Allianz Asset Management GmbH - MarketBeat

Fri, 06 Feb 2026
What GRAIL (GRAL)'s FDA PMA Submission for Galleri Test Means For Shareholders - Sahm

Mon, 02 Feb 2026
GRAIL Inc (GRAL) Shares Up 3.77% on Feb 2 - GuruFocus

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 39 (M)
Shares Float 33 (M)
Held by Insiders 10.2 (%)
Held by Institutions 65.5 (%)
Shares Short 5,370 (K)
Shares Short P.Month 4,730 (K)
Stock Financials
EPS -10.33
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 61.93
Profit Margin -286.5 %
Operating Margin -346.2 %
Return on Assets (ttm) -11.1 %
Return on Equity (ttm) -16.9 %
Qtrly Rev. Growth 26.2 %
Gross Profit (p.s.) -1.73
Sales Per Share 3.63
EBITDA (p.s.) -8.97
Qtrly Earnings Growth 0 %
Operating Cash Flow -329 (M)
Levered Free Cash Flow -59 (M)
Stock Valuations
PE Ratio -9.72
PEG Ratio 0
Price to Book value 1.62
Price to Sales 27.59
Price to Cash Flow -11.91
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android